Literature DB >> 35175614

Graphene-Based Nanomaterials as Drug Delivery Carriers.

Woo Yeup Jeong1, Hye Eun Choi1, Ki Su Kim2,3.   

Abstract

Graphene and graphene-based materials have been attracted in the past few years for biomedical applications due to their physicochemical and biological properties such as large surface area, chemical and mechanical stability, excellent conductivity, and good biocompatibility. Graphene-based materials not only surface modified graphene-based materials like graphene oxide (GO) or reduced graphene oxide (rGO) but also other structural forms like fullerene, carbon nanotubes, and graphite have been applied to advanced drug delivery systems. In this chapter, we review on the application of graphene-based materials in the drug delivery system with their physicochemical properties, methods for the preparation of graphene-based carriers, followed by analysis about their biodistribution and biosafety whether they are suitable as drug delivery carriers.
© 2022. Springer Nature Singapore Pte Ltd.

Entities:  

Keywords:  Drug delivery system; Graphene; Graphene-based materials

Mesh:

Substances:

Year:  2022        PMID: 35175614     DOI: 10.1007/978-981-16-4923-3_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  33 in total

1.  Graphene based gene transfection.

Authors:  Liangzhu Feng; Shuai Zhang; Zhuang Liu
Journal:  Nanoscale       Date:  2011-01-27       Impact factor: 7.790

2.  Structural evolution during the reduction of chemically derived graphene oxide.

Authors:  Akbar Bagri; Cecilia Mattevi; Muge Acik; Yves J Chabal; Manish Chhowalla; Vivek B Shenoy
Journal:  Nat Chem       Date:  2010-06-06       Impact factor: 24.427

3.  Functionalized graphene oxide as nanocarrier for loading and delivery of ellagic Acid.

Authors:  M Kakran; N G Sahoo; H Bao; Y Pan; L Li
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

4.  Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.

Authors:  A Angelopoulou; E Voulgari; E K Diamanti; D Gournis; K Avgoustakis
Journal:  Eur J Pharm Biopharm       Date:  2015-03-24       Impact factor: 5.571

5.  Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery.

Authors:  Hongqian Bao; Yongzheng Pan; Yuan Ping; Nanda Gopal Sahoo; Tongfei Wu; Lin Li; Jun Li; Leong Huat Gan
Journal:  Small       Date:  2011-04-28       Impact factor: 13.281

6.  The rise of graphene.

Authors:  A K Geim; K S Novoselov
Journal:  Nat Mater       Date:  2007-03       Impact factor: 43.841

Review 7.  Prospects and challenges of graphene in biomedical applications.

Authors:  Dimitrios Bitounis; Hanene Ali-Boucetta; Byung Hee Hong; Dal-Hee Min; Kostas Kostarelos
Journal:  Adv Mater       Date:  2013-03-13       Impact factor: 30.849

8.  Magnetic Fe3O4-graphene composites as targeted drug nanocarriers for pH-activated release.

Authors:  Xiujuan Fan; Guozheng Jiao; Wei Zhao; Pengfei Jin; Xin Li
Journal:  Nanoscale       Date:  2013-01-04       Impact factor: 7.790

9.  Large-area ultrathin films of reduced graphene oxide as a transparent and flexible electronic material.

Authors:  Goki Eda; Giovanni Fanchini; Manish Chhowalla
Journal:  Nat Nanotechnol       Date:  2008-04-06       Impact factor: 39.213

10.  Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors.

Authors:  Bart Cornelissen; Sarah Able; Veerle Kersemans; Philip A Waghorn; Sverre Myhra; Kerstin Jurkshat; Alison Crossley; Katherine A Vallis
Journal:  Biomaterials       Date:  2012-11-19       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.